SIGN UP
LOG IN
M
MRVI
Maravai Lifesciences Holdings, I…
2.04
-0.03-1.21%After Hours: 2.060 +0.015 +0.73%19:30 04/25 EDT
OPEN/PREV CLOSE2.070/2.070
TODAY RANGE1.980-2.070
VOL1.15M
MARKET CAP520.74M
52 WEEK RANGE1.665-11.56
AVG VOL (3M)3.36M
% TURNOVER0.45%
TURNOVER--
P/E (TTM)-1.9471
% RANGE4.35%
EPS(TTM)-1.0503
P/E(FORWARD)-3.8585
P/B1.588
BVPS1.288
DIVIDEND--
P/S1.994
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP244.14M
SHARES OUTSTANDING254.64M
NEXT EARNINGS05/06-05/12
FREE FLOAT119.39M
LOT SIZE1
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
NASDAQ·04/10 15:34
QuidelOrtho (QDEL) Surges 10.1%: Is This an Indication of Further Gains?
TipRanks·04/09 01:50
RBC Capital Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
Seeking Alpha·04/04 18:34
Maravai LifeSciences: Upside Not Likely In 2025, But Company Can Survive
TipRanks·04/03 01:47
RBC Capital Sticks to Its Buy Rating for Maravai Lifesciences Holdings (MRVI)
Seeking Alpha·03/26 15:10
Columbia Acorn Fund Q4 2024 Commentary
TipRanks·03/25 19:47
Maravai Lifesciences price target lowered to $5 from $7 at Morgan Stanley
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.